[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354434-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354434-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integration-of-tumor-microenvironment-and-metabolic-signatures-reveals-tmpi-defined-prognostic-and-immunotherapy-relevant-phenotypes-in-breast-cancer","Integration of tumor microenvironment and metabolic signatures reveals TMPI-defined prognostic and immunotherapy-relevant phenotypes in breast cancer","","Breast cancer heterogeneity limits effective diagnosis and treatment, requiring deeper clarification of tumor microenvironment (TME) biology and metabolic behavior. This study integrates RNA-sequencing evidence from bulk and single-cell datasets to examine TME components linked to metabolism. Transcriptomic and clinical data are sourced from TCGA and GEO, with qPCR and immunohistochemistry for experimental validation. A TMPI-related high-risk phenotype connects NAD+ metabolism with impaired T- and NK-cell activity and worse prognosis. TMPI also aligns with immune-desert/excluded states and treatment-response patterns across immunotherapy cohorts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integration-of-tumor-microenvironment-and-metabolic-signatures-reveals-tmpi-defined-prognostic-and-immunotherapy-relevant-phenotypes-in-breast-cancer/354434/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integration-of-tumor-microenvironment-and-metabolic-signatures-reveals-tmpi-defined-prognostic-and-immunotherapy-relevant-phenotypes-in-breast-cancer/354434.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding breast cancer?","Question",{"text":63,"@type":64},"To define how tumor microenvironment (TME) components interact with metabolic dynamics and how this relates to prognosis and immunotherapy-relevant phenotypes in breast cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were transcriptomic data and clinical information obtained and validated?",{"text":68,"@type":64},"Transcriptomic data and clinical information were retrieved from TCGA and GEO databases, followed by qPCR and immunohistochemistry (IHC) for experimental validation. Data analyses used R software.",{"name":70,"@type":61,"acceptedAnswer":71},"What is TMPI and what does it capture?",{"text":72,"@type":64},"TMPI is a 23-gene risk model built using LASSO regression. It refines prognostic stratification and links TME–metabolism crosstalk to immune-related tumor microenvironment states.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354434,1790895152,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Original Research PUBLISHED 22 June 2026  \nDOI 10.3389/fphar.2026.1852654  \nOPEN ACCESS  \nEDITED BY  \nMahan Gholam Azad,  \nThe University of Queensland, Australia  \nREVIEWED BY  \nRuo Wang,  \nShanghai Jiao Tong University, China Yixuan Ma,  \nShaanbei Key Laboratory for Cancer Prevention of Yan’an, China  \n*CORRESPONDENCE  \nJiacai Ye,  \n [21376689@qq.com](21376689@qq.com)[ ](21376689@qq.com)Yunyu Wu,  \n [symwu928@sina.com](symwu928@sina.com)  \n†These authors have contributed equally to this work  \nRECEIVED 10 April 2026  \nREVISED 08 May 2026  \nACCEPTED 22 May 2026  \nPUBLISHED 22 June 2026  \nCITATION  \nHuang Z, Lin S, Liang Y, Khan M, Chen W, Li X, Liu X, Wu Y and Ye J (2026)  \nIntegration of tumor microenvironment and metabolic signatures reveals TMPIdefined prognostic and immunotherapyrelevant phenotypes in breast cancer. Front. Pharmacol. 17:1852654 .  \ndoi: 10.3389/fphar.2026.1852654  \nCOPYRIGHT  \n© 2026 Huang, Lin, Liang, Khan, Chen, Li, Liu, Wu and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntegration of tumor microenvironment and metabolic signatures reveals TMPI-defined prognostic and immunotherapy-relevant phenotypes in breast cancer  \nZhong Huang 2†, Shuhui Lin 3†, Ying Liang 2†, Muhammad Khan 2, Weirui Chen 2, Xuefeng Li 3, Xiaolan Liu 4, Yunyu Wu 5* and Jiacai Ye 1*  \n1Department of Radiation Oncology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China, 2Department of Radiation Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China, 3Department of Radiation Oncology, Shenzhen Nanshan People’s Hospital, Shenzhen, Guangdong, China, 4Guangzhou Liwan Maternal & Child Health Hospital, Guangzhou, Guangdong, China, 5Department of Gynecologic Oncology, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China  \nBackground: Breast cancer heterogeneity presents a significant challenge for effective diagnosis and treatment. A deeper understanding of the tumor microenvironment (TME) and its metabolic dynamics is essential for addressing this complexity. This study explored the interplay between TME components and metabolic profiles in breast cancer using RNA sequencing data from both bulk and single-cell analyses.  \nMethods: Transcriptomic data and corresponding clinical information for breast cancer patients were obtained from TCGA and GEO databases. qPCR and immunohistochemistry (IHC) were performed for experimental validation. Data analyses were conducted using R software.  \nResults: A high-risk phenotype was identified based on 36 interconnected genes primarily associated with the TME and metabolic processes. This phenotype demonstrated enrichment of nicotinamide adenine dinucleotide (NAD+) metabolism and was associated with reduced T- and NK-cell activity within the TME, contributing to poor prognosis in HER2 and Luminal B breast cancer subtypes. Using Least Absolute Shrinkage and Selection Operator (LASSO) regression, a 23-gene risk model (TMPI) was established, which further refined prognostic stratification and highlighted elevated risk in HER2 and Luminal B contexts. Immune and stromal analyses, along with single-cell validation, revealed that key NAD metabolism genes (NMNAT2 and QPRT) and the adenosine pathway enzyme NT5E were predominantly expressed in stromal and malignant cell populations, including endothelial cells and fibroblasts. qPCR validation confirmed subtype-specific expression patterns, with NMNAT2 and","cbCaioUAh74L1rrH","https://ap.wps.com/l/cbCaioUAh74L1rrH","pdf",11288855,22,"English","# Background\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Introduction","[{\"question\":\"What is the study’s main goal regarding breast cancer?\",\"answer\":\"To define how tumor microenvironment (TME) components interact with metabolic dynamics and how this relates to prognosis and immunotherapy-relevant phenotypes in breast cancer.\"},{\"question\":\"How were transcriptomic data and clinical information obtained and validated?\",\"answer\":\"Transcriptomic data and clinical information were retrieved from TCGA and GEO databases, followed by qPCR and immunohistochemistry (IHC) for experimental validation. Data analyses used R software.\"},{\"question\":\"What is TMPI and what does it capture?\",\"answer\":\"TMPI is a 23-gene risk model built using LASSO regression. It refines prognostic stratification and links TME–metabolism crosstalk to immune-related tumor microenvironment states.\"}]","Integration of tumor microenvironment and metabolic signatures reveals TMPI-defined prognostic and immunotherapy-relevant phenotypes in breast cancer | PDF",1790110642,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f41b3ec72fce3d865b6f95e3cc474ba.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/352096233168b9bbd3b141adcdd0e9ce.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb1f07dbeb4d6c97fbf0a1e18476ebc6.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2e7f0da44dabbcd1cf143b5dc06f6dc.webp",980,1385]